Title Page
-
Site conducted
-
Facility:
-
Audit Date & Time:
-
Attendees:
-
Auditor:
-
Location:
Facility Review
RECEIVING
-
1. Are there written procedures for the receipt, identification, storage, handling, sampling, testing and approval of components (ingredients),packaging materials, and Labels?
-
2. Are components (ingredients), containers and closures withheld from production until released by Q.C.?
-
3. Do incoming fragrance oils have unique handling requirements, including inspection, testing, and release criteria.
-
4. Are components (ingredients) status labeled or held in a quarantine area until released for use?
-
5. Are packaging materials status labeled or held in a quarantine area until released for use?
-
6. Is there a representative sized sample taken?
-
7. Are the component (ingredient) containers cleaned before sampling?
-
8. Are the components (ingredients) sampled and resealed in a manner and in an area designed to prevent contamination?
-
9. Are component (ingredient) samples labeled with lot number, container, the date and the person who collected the sample?
-
10. Are the components (ingredients) tested by at least one identity test?
-
11. Are COA’s required for component (ingredient) approval?
-
12. Are COA's obtained for packaging components and labels?
-
13. Are representative samples of each lot of raw material pulled and tested/examined for physical, chemical and/or microbiological characteristics as specified?
-
14. Are bagged or boxed raw materials stored off the floor?
-
15. Is FIFO used for component (ingredient)s, containers and closures?
-
16. Is there a system to identify expired component (ingredient)s and quarantine them to prevent their use?
-
17. Is there a quarantine system for rejected component (ingredient)s and packaging materials designed to prevent their use?
-
18. Are fragrance oils reinspected prior to use to ensure oil still meets standard?
WEIGH AREA
-
19. Are there written procedures for weighing, labeling (the intermediate container) and documenting the weighing of components (ingredients)?
-
20. Is the reproduction of the master production record, checked for accuracy, dated and signed?
-
21. Is the intermediate component (ingredient) container labeled with; name or code, control number, weight, and batch for which it is designated?
-
22. Is the component (ingredient) weighing examined by a second person for component release, for correct weight as in production record, and for correctly labeled container?
-
23. Is the weigh area a controlled environment to prevent contamination of open containers of components (ingredients)?
-
24. Are the intermediate containers constructed of appropriate materials to prevent contamination and to facilitate cleaning?
-
25. Are batch adjustments documented as part of the batch record?
CALIBRATION
-
26. Are there written procedures for calibration of weigh scales and other measurement instruments?
-
27. Is there an instrument list of all the measurement instruments that require calibration?
-
28. Is there documentation of periodic calibration of the measurement instruments showing that the instruments were calibrated on schedule to a preset tolerance and with a traceable reference standard?
INGREDIENT WATER SYSTEM
-
29. Are there written procedures for the operation, cleaning, maintenance and sanitization of the ingredient water system?
-
30. Is the ingredient water system validated and follow USP (FDA) guidlines for Purified Water?
-
31. Is there a diagram of the water system showing all sample points and use points?
-
31. A. Is the ingredient water system free of deadlegs and constructed of material to prevent contamination
-
32. Is there an ongoing water quality monitoring program with alert and action limits?
PROCESSING AREA
-
33. Are there written production and process control procedures approved by the QC unit?
-
34. Are product production processes (manufacturing instructions / processes) validated by both the factory and R&D?
-
35. Are there written procedures for the cleaning and sanitation of equipment?
-
36. Is the cleaning/sanitization procedure validated?
-
37. Are there cleaning/sanitization records for the equipment?
-
38. Is the equipment cleaning/sanitization status labeled?
-
39. Is the equipment inspected for cleanliness before use and documented in the production record?
-
40. Is the equipment located to facilitate operations, cleaning and maintenance?
-
41. Is the equipment constructed of appropriate materials to prevent contamination and to facilitate cleaning?
-
42. Is the equipment designed to prevent contamination with lubricants and coolants?
-
43. Are all major equipment identified and documented in the batch production record?
-
44. Is the component (ingredient) addition verified by a second person?
-
45. Are key processing steps and parameters documented in the production records i.e.. mixing speed, mixing times and temperatures?
FILLING AND PACKAGING AREA
-
46. Are there written filling and packaging control procedures approved by the QC unit?
-
47. Are product filling processes (manufacturing instructions / fill and assembly) validated by both factory and R&D?
-
48. Is line clearance between batches documented?
-
49. Are there written procedures for the cleaning and sanitization of filling equipment?
-
50. Are cleaning and sanitization methods validated to prevent chemical residue on equipment?
-
51. Are the cleaning and sanitization procedures for filling equipment validated?
-
52. Are there cleaning/sanitation records for the filling equipment?
-
53. Is the equipment inspected for cleanliness before use?
-
54. Is the equipment located to facilitate operations, cleaning and maintenance?
-
55. Is the equipment constructed of appropriate materials to prevent contamination and to facilitate cleaning?
-
56. Is the equipment designed to prevent contamination with lubricants and coolants?
-
57. Is the compressed air that comes into product contact or contact with primary containers or other product contact surfaces oil-free and micro filtered?
-
58. Are actual yield calculations determined at the end of filling and verified by a second person?
-
59. Are labels held in quarantine until issued to the production area?
-
60. Are labels and other proprietary components cleared, stored, and/or destructed post production?
-
61. Is finished product examined during finishing to assure correct labeling?
-
62. Are production samples retained for at least three years from manufacture?
-
63. Are finished product standards refreshed every 6 months?
-
64. Are finished product standards stored in an environmentally controlled area to prevent product contamination and degradation?
HOLDING AND DISTRIBUTION
-
65. Are there written warehousing procedures describing quarantine of manufactured products (bulk or finished goods) until approved by QC?
-
66. Is rejected finished products status labeled or held in a quarantine area?
-
67. Are there written procedures for disposal of rejected finished product in a manner that assures it is not used?
-
68. Is there a SOP that describes the requirements for product release, specification compliance, samples and documents?
-
69. Is there a SOP or system to limit the storage of manufactured bulk for a validated period of time?
-
70. If stored for a period of time, is bulk retested for micro prior to use?
LOSS PREVENTION
-
71. Are there adequate controls to prevent the loss of finished goods and/or componentry from the facility?
-
72. Is facility access controlled and monitored after hours? Are the access records reviewed?
-
73. Are procedures in place for the proper notification and destruction of unacceptable/obsolete finished goods and/or package components?
-
74. Are products shipped in a controlled & secured manner to prevent tampering, contamination or loss during transit?
BUILDING AND FACILITIES
-
75. The outside of the building is maintained free of trash and debris that provide harborage.
-
76. The building size and construction facilitate cleaning maintenance and operations.
-
77. There is adequate space to prevent mix-ups of component (ingredient)s, labels, materials, and to prevent contamination.
-
78. Doors and windows are kept closed.
-
79. Operations are performed within specifically defined areas to prevent contamination or mix-ups.
-
80. Is there adequate lighting?
-
81. Is there adequate filtered ventilation to production operations where product is exposed?
-
82. There are adequate drains for equipment and to prevent standing water.
-
83. The building is free of signs of infestation.
-
84. There are written procedures for pest control including a drawing or floor plan showing the placement of control devices.
-
85. Is the building maintained in a good state of repair?
Record & Documentation Review
BATCH PRODUCTION RECORDS
-
86. Is the QC unit review of the records documented?
-
87. Does the review result in a shipping release document?
-
88. Was all testing completed before the shipping release was signed?
-
89. Is the Formula change control documented?
-
90. For first production has the contract manufacturer established an internal procedure to identify the First Production batches. Give written notification at least 48 hours before start-up. Assure that before start-up there is an approved formula, approved standard, approved specification, fill and assembly specification and packaging specification?
-
91. Are all batch related instructions and forms combined into a comprehensive batch packet? Are records retrievable within 24 hours?
-
92. Are batch records for retained for at least 4 years and/or the time period required by local regulations?
REGISTERED FACILITY
-
93. Has the facility been registered with local governing agencies as a cosmetic, chemical, or similar manufacturing facility and has received approval to manufacture legally within the guidelines as specified by the registration?
-
94. Has the facility been certified, under local governing agencies and/or to a international standard for the manufacturing of cosmetic, chemical or similar products? (Ex. IS0 9001, ISO 22716, USFDA, Korean FDA, China FDA, etc.)
-
95. When was the last local FDA inspection? Have any major non-compliances and/or fines been issued in the past 10 years? (Ex. FDA-483)
-
96. Are batch production records retained for one year past expiration date?
-
97. Are there written procedures for an annual review of written records; batch production records, complaints, recalls and investigations?
-
98. Is there a record of the most recent required review for Mast products? Or an example of a review from a similar customer?
-
99. Are their established requirements and/or certifications required for all subcontractors and suppliers?
QUALITY CONTROL
-
100. Does the facility have a Quality Manual? Is the manual updated and audited through change control?
-
101. Does the QC unit have written procedures to approve or reject all component (ingredient)s, containers, closures, in-process materials, packaging material, labeling, and finished products?
-
102. Are adequate laboratory facilities available to the QC unit for testing and approval or rejection of all component (ingredient)s, in-process materials, packaging material, labeling, and finished product?
-
103. Does the QC unit approve all procedures and specifications impacting the identity, strength, quality, and purity of the product.
-
104. Does the QC Unit review production records prior to release or shipping the product?
-
105. Is there history of internal and/or external quality holds, withdrawals or recalls?
-
106. Is batch data trended to ensure processes are in control?
-
107. Is there an appropriate CAPA system in place to identify and resolve quality based issues?
-
108. Are finished goods inspected properly by QC prior to release for shipping?
-
109. Does the vendor audit their raw material suppliers?
PERSONNEL QUALIFICATIONS
-
110. Is there a record of training in GMP and in the particular operations each employee performs?1
-
111. Is the training conducted by a qualified individual and is a retraining cadence specified?
-
112. Do the personnel use protective apparel such as head, face and arm coverings properly to prevent product contamination?
DEVELOPMENT TESTING
-
113. If applicable, are OTC products formulated to provide not less than 100% of the labeled amount of active ingredient?
-
114. Was preservative challenge testing completed on the product formulation prior to first production?
-
115. Was RIPT testing completed before first production? (Human Repeat Insult Patch Test)
-
116. Is there a written stability program? Does this stability program meet Mast stability testing protocols?
-
117. Is there documentation of the setting of the tentative expiration date?
-
118. Is the DOT hazardous material labeling assessment documented?
-
119. Are there actual shelf life studies underway to support the tentative expiration date?
-
121. Is there preservative challenge testing on aged samples to show the preservative effectiveness at expiration?
-
120. If applicable, is there a test method validation for the active ingredient assay?
SIGN-OFF
-
Auditor's Name & Signature: